MORGAN STANLEY

Position in NVO — Novo Nordisk A S

CIK 895421 NEW YORK, NY

Back to NVO Full portfolio

Position in NVO

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$558,974,112

+$159,531,019 QoQ

Shares Held

11,659,869

+7.3% QoQ

Ownership

0.264%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

of 1,348 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 75% Shared 0% None 25%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $63,698,443,803 across 20 Drug Manufacturers - General names. NVO ranks #11 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	16,226,398	$19,462,430,163
2	JNJ	Johnson & Johnson	44,808,254	$11,379,952,259
3	ABBV	AbbVie Inc.	38,901,001	$9,789,047,884
4	MRK	Merck & Co., Inc.	48,641,158	$6,250,388,797
5	AMGN	Amgen Inc	13,653,692	$4,944,274,940
6	GILD	Gilead Sciences, Inc.	24,004,354	$3,032,710,073
7	PFE	Pfizer Inc	96,345,452	$2,319,998,477
8	BMY	Bristol Myers Squibb Co	29,009,025	$1,671,500,010

All Filings in NVO

Export CSV

26 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$558,974,112	11,659,869	+7.3%	Shares	Defined	2026-08-13
2026-03-31	$399,443,093	10,869,200	-15.4%	Shares	Defined	2026-05-15
2025-12-31	$653,405,482	12,842,089	+3.5%	Shares	Defined	2026-05-27
2025-09-30	$688,821,166	12,413,429	-13.1%	Shares	Defined	2026-05-27
2025-06-30	$985,936,197	14,284,790	+15.9%	Shares	Defined	2025-08-15
2025-03-31	$855,486,003	12,319,787	+0.9%	Shares	Defined	2025-05-15
2024-12-31	$1,049,813,188	12,204,292	-15.0%	Shares	Defined	2025-05-15
2024-09-30	$1,710,488,408	14,365,402	-1.7%	Shares	Defined	2025-05-14
2024-06-30	$2,085,559,859	14,610,900	+21.6%	Shares	Defined	2025-05-14
2024-03-31	$1,542,321,921	12,011,853	+13.2%	Shares	Defined	2024-10-17
2023-12-31	$1,098,102,192	10,614,811	+15.2%	Shares	Defined	2024-08-16
2023-09-30	$838,021,007	9,215,098	+96.5%	Shares	Defined	2023-11-15
2023-06-30	$758,804,519	4,688,899	+1.9%	Shares	Defined	2023-08-14
2023-03-31	$732,476,218	4,602,716	-11.7%	Shares	Defined	2023-05-15
2022-12-31	$705,445,937	5,212,398	+39.4%	Shares	Defined	2023-02-14
2022-09-30	$372,601,053	3,739,848	+2.2%	Shares	Defined	2022-11-14
2022-06-30	$407,600,462	3,657,906	+322.5%	Shares	Defined	2022-10-27
2022-03-31	$96,134,762	865,689	-8.0%	Shares	Defined	2022-10-27
2021-12-31	$105,369,824	940,802	+2.5%	Shares	Defined	2022-02-14
2021-09-30	$88,149,180	918,125	+4.4%	Shares	Defined	2021-11-15
2021-06-30	$73,691,713	879,691	+14.1%	Shares	Defined	2021-08-23
2021-03-31	$51,992,348	771,171	-31.3%	Shares	Defined	2021-05-17
2020-12-31	$78,355,354	1,121,766	+22.5%	Shares	Defined	2021-02-16
2020-09-30	$63,561,913	915,482	-0.8%	Shares	Defined	2020-11-13
2020-06-30	$60,431,359	922,898	+13.2%	Shares	Defined	2020-08-14
2020-03-31	$49,097,794	815,578	—	Shares	Defined	2020-05-26
No filing history on record for this holder in this stock.